Inhalable siRNA Nanoparticles for Enhanced Tumor-Targeting Treatment of <i>KRAS</i>-Mutant Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Inhalable siRNA Nanoparticles for Enhanced Tumor-Targeting Treatment of KRAS-Mutant Non-Small-Cell Lung Cancer

Published:2023-06-24 Issue:26 Volume:15 Page:31273-31284
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Zhao Guolin¹²,Ho William³,Chu Jinxian¹²,Xiong Xiaojian¹²,Hu Bin¹²,Boakye-Yiadom Kofi Oti¹²,Xu Xiaoyang³⁴^ORCID,Zhang Xue-Qing¹²^ORCID

Affiliation:

1. Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China

2. National Key Laboratory of Innovative Immunotherapy, Shanghai Jiao Tong University, Shanghai 200240, China

3. Department of Chemical and Materials Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States

4. Department of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States

Funder

Natural Science Foundation of Shanghai

Shanghai Jiao Tong University

Gustavus and Louise Pfeiffer Research Foundation

National Natural Science Foundation of China

Foundation of National Facility for Translational Medicine (Shanghai)

Key Technology Program for Nucleic Acid Drugs of NCTIB

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.3c05007

Reference58 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives

3. Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations

4. Biodegradable nanoparticles decorated with different carbohydrates for efficient macrophage-targeted gene therapy

5. KRAS inhibition in non–small cell lung cancer: Past failures, new findings and upcoming challenges

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine;Pharmaceuticals;2024-08-12

2. Advanced gene therapy system for the treatment of solid tumour: A review;Materials Today Bio;2024-08

3. The Role of Inhaled Chitosan-Based Nanoparticles in Lung Cancer Therapy;Pharmaceutics;2024-07-23

4. Establishment of an Inhalation Administration Non-invasive Murine Model for Rapidly Testing Drug Activity againstMycobacterium tuberculosis;2024-02-27

5. A novel therapeutic outlook: Classification, applications and challenges of inhalable micron/nanoparticle drug delivery systems in lung cancer (Review);International Journal of Oncology;2024-02-21